跳至主要内容
临床试验/TCTR20230317003
TCTR20230317003尚未招募2 期

Therapeutic efficiency and safety assessment of intradermal platelet rich plasma combined with oral tranexamic acid in patients with facial melasma

WU grant, Walailak university0 个研究点目标入组 20 人开始时间: 2023年3月17日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Age 18-60 years
  • 2. Diagnosed with facial melasma by dermatologists

排除标准

  • 1. Not willing to participate to the study
  • 2. Allergic to lidocaine, prilocaine, tranexamic acid, chlorhexidine or isopropyl alcohol
  • 3. Allergic to blood components
  • 4. Currently treated with other modalities of melasma (or within 6 months)
  • 5. Pregnancy or lactation
  • 6. History of hematologic disorders
  • 7. History of neurologic disorders
  • 8. History of cancer
  • 9. Hormonal therapy
  • 10. Smoking/alcohol drinking
  • 11. Abnormal liver function test (alanine aminotransferase > 5 times upper normal limits)
  • 12. Abnormal creatinine (serum creatinine > 3.5 mg/dL)
  • 13. Methemoglobinemia
  • 14. Sepsis

研究者

发起方
WU grant, Walailak university

相似试验